<strong>Guidelines</strong> <strong>for</strong> iodine prophylaxis <strong>following</strong> nuclear accidents1999 updateAcknowledgementsWHO acknowledges with gratitude the scientific input and theprofessional opinions of all individuals, endocrinologists andemergency preparedness specialists who have contributed to thefinalization of this document.Special acknowledgements are made to Dr Wendla Paile and Mr LeifBlomqvist of the Finnish <strong>Nuclear</strong> Safety Authority, the two WHOconsultants who have prepared this document.The <strong>Guidelines</strong> were extensively reviewed by the <strong>following</strong> experts onendocrinology and emergency preparedness nominated by WHO andIAEA:Ms Eliana C.S. Amaral, Director, Institute <strong>for</strong> Radioprotection andDosimetry, BrazilDr David V. Becker, Director, Division of <strong>Nuclear</strong> Medicine, NewYork Hospital, USADr David Brown, Institute of Naval Medicine, United KingdomDr Frank J. Congel, Incident Response Division, US <strong>Nuclear</strong> RegulatoryCommission, USADr François Delange, Executive Director, International Council <strong>for</strong>Control of <strong>Iodine</strong> Deficiency Disorders, BelgiumDr John Harrison, Assistant Director, NRPB, United KingdomMr F. Owen Hoffmann, Director, Centre <strong>for</strong> Risk Analysis, USADr L. Van Middlesworth, University of Memphis, Tennessee, USAProfessor Janusz Nauman, Warsaw University Medical School,PolandDr Jean-Claude Nenot, Centre d’études nucléaires, FranceProfessor Aldo Pinchera, University of Pisa, ItalyDr E.D Rubery, Department of Health, United KingdomDr John Standbury, International Council <strong>for</strong> Control of <strong>Iodine</strong>Deficiency Disorders, USAProfessor Nikolaj Dmitrievitch Tronko, Kiev Institute ofEndocrinology and Metabolism of the Academy of Sciences, UkraineDr Hilary Walker Department of Health, United KingdomProfessor Dillwyn Williams, Strangeways Research Laboratories,United KingdomDr Jan Wolffe, National Cancer Institute, USA23
<strong>Guidelines</strong> <strong>for</strong> iodine prophylaxis <strong>following</strong> nuclear accidents1999 updateThe <strong>for</strong>mal review of the document was carried out by the <strong>following</strong>representatives of the four regional thyroid associations and by the<strong>following</strong> experts:American Thyroid Association (ATA)Dr David V. Becker, Director, Division of <strong>Nuclear</strong> Medicine, NewYork Hospital, USADr Martin I. Surks, Montefiore Medical Center & Albert EinsteinCollege of Medicine, USALatin American Thyroid Society (LATS)Dr Edna Teruko Kimura, Universidade de Sao Paolo, BrazilDr Mario A. Pisarev, Comision Nacional de Energia, ArgentinaAsia and Oceania Thyroid Association (AOTA)Dr Shigenobu NagatakiEuropean Thyroid Association (ETA)Dr John H. Lazarus, Department of Medicine, Llandough Hospital,United KingdomDr Elena Bouglova, Research Clinical Institute of Radiation Medicineand Endocrinology, Minsk, BelarusMr Aubrey Godwin, Director, Radiation Agency, Arizona, USAWHO also acknowledges with gratitude the support provided byMs Diane Miller, Administrator of the American Thyroid Associationin the organization of the Oregon Meeting where the <strong>for</strong>mal review ofthe document was carried out.The guidelines <strong>for</strong> stable iodine prophylaxis have been <strong>for</strong>mallyendorsed by the Latin American Thyroid Society, the Asia andOceania Thyroid Association and the European Thyroid Association.24